Literature DB >> 3469161

Ofloxacin: concentration in human ejaculate and influence on sperm motility.

P Schramm.   

Abstract

The concentration of ofloxacin was measured in both fractions of split-ejaculate from five volunteers treated with ofloxacin 400 mg/day for 3.5 consecutive days. Concentrations in both fractions were equal, 2.44 mg/l and 2.5 mg/l, respectively indicating that the penetration of ofloxacin into the prostate gland and into the vesical glands are of the same magnitude. Sperm motility was not affected by ofloxacin in a concentration of 4.5 mg/l as tested on fresh ejaculate of 29 andrologic patients. Thus ofloxacin proves to be useful as a potent antibiotic in clinical care for andrologic patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469161     DOI: 10.1007/BF01661292

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  [Suppression of phagocyte function by seminal plasma: possible predisposition for AIDS].

Authors:  R E Schopf; M Trompeter; P Benes; B Morsches; P Schramm
Journal:  Hautarzt       Date:  1986-12       Impact factor: 0.751

2.  Seminal plasma-induced suppression of the respiratory burst of polymorphonuclear leukocytes and monocytes.

Authors:  R E Schopf; P Schramm; P Benes; B Morsches
Journal:  Andrologia       Date:  1984 Mar-Apr       Impact factor: 2.775

3.  [Seminal fluid concentration of ketoconazole and its effect on spermatozoa motility].

Authors:  P Schramm
Journal:  Z Hautkr       Date:  1984-02-01

4.  Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.

Authors:  G Seibert; M Limbert; N Klesel
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

5.  [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].

Authors:  G Seibert; N Klesel; M Limbert; E Schrinner; I Winkler
Journal:  Arzneimittelforschung       Date:  1984
  5 in total
  7 in total

Review 1.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.

Authors:  K G Naber; D Adam; F Kees
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate.

Authors:  Themba T Ndovi; Teresa Parsons; Leena Choi; Brian Caffo; Charles Rohde; Craig W Hendrix
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

4.  Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid.

Authors:  K G Naber; M Kinzig; F Sörgel; D Weigel
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

Review 5.  Drugs in semen.

Authors:  S Pichini; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

Review 6.  Use of quinolones in treatment of prostatitis and lower urinary tract infections.

Authors:  V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 7.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.